Peiping Xu | Medical Science | Best Researcher Award

Posted on by PencisLeave a Comment on Peiping Xu | Medical Science | Best Researcher Award

Dr. Peiping Xu | Medical Science | Best Researcher Award

Guangzhou University of Chinese Medicine | China

Author Profile

Scopus

Xu Peiping: Pioneering Research Fellow in Traditional Chinese Medicine 🌿🧬

EARLY ACADEMIC PURSUITS 🎓

Xu Peiping’s academic journey laid a solid foundation for a career dedicated to groundbreaking research in antiviral pharmacology and the field of traditional Chinese medicine (TCM). Xu pursued rigorous studies in pharmacology and related fields, gaining expertise that would later inform innovative approaches to studying TCM's molecular mechanisms. This strong academic background has been instrumental in shaping Xu’s approach to leveraging modern technologies like bioinformatics and artificial intelligence to explore TCM's antiviral potential.

PROFESSIONAL ENDEAVORS AND APPOINTMENTS 🏛️

Currently a Research Fellow at the Institute of Tropical Medicine, Guangzhou University of Chinese Medicine, Xu Peiping has made significant contributions to advancing the scientific understanding of TCM. Xu’s role at this prestigious institution involves leading projects that investigate TCM's antiviral and immune-modulatory effects. This research aims to bridge the gap between traditional and modern medicine, using cutting-edge technologies to expand the application of TCM in contemporary medical science. Xu is a sought-after expert in interdisciplinary research and is known for fostering collaborations across both national and international platforms to promote TCM research.

CONTRIBUTIONS AND RESEARCH FOCUS ON MEDICAL SCIENCE 🔬

Xu’s research focuses on the molecular mechanisms underlying antiviral effects and inflammatory immune pharmacology within TCM. By applying technologies such as computer-aided drug design, network pharmacology, systems pharmacology, bioinformatics, and AI, Xu’s work uncovers how TCM formulations interact with viral mechanisms and immune responses at a molecular level. This approach provides a scientific basis for TCM's efficacy, opening the door to more targeted antiviral therapies and innovative pharmaceutical applications.

IMPACT AND INFLUENCE 🌏

Xu Peiping's research has not only contributed to scientific knowledge but has also driven significant advancements in public health. The work on TCM’s antiviral and immune-modulatory properties has garnered considerable attention within the medical community and among policymakers who see TCM as an important resource in global health. Xu’s findings are particularly impactful in regions where TCM is integrated into healthcare systems, and his research has influenced policy discussions about TCM's role in preventive and curative healthcare strategies.

ACADEMIC CITES AND RECOGNITION 🏅

Xu’s work is widely cited in leading pharmacological and medical journals, reflecting a respected position within the academic community. Through numerous peer-reviewed publications, Xu’s research has contributed significantly to understanding TCM's pharmacology, reinforcing the academic credibility of traditional remedies. Xu has also been recognized with awards that highlight contributions to pharmacology, demonstrating his expertise and commitment to both scientific innovation and the future of TCM.

LEGACY AND FUTURE CONTRIBUTIONS 🌟

Xu Peiping’s legacy in the field of TCM is one of bridging traditional and modern science to address pressing health challenges. His pioneering research is shaping a future where integrative medicine, powered by modern technologies, enhances our understanding and utilization of traditional treatments. Xu’s ongoing work in TCM-based antiviral and immunological research continues to inspire new generations of researchers to explore the intersection of technology and traditional medicine, ensuring that his contributions will have a lasting impact on both the field of pharmacology and public health.

NOTABLE PUBLICATIONS 📑

"Identification and Analysis of Biomarkers Associated with Lipophagy and Therapeutic Agents for COVID-19" 

  • Authors: Wu, Y. , Wu, Z. , Jin, Q. , Liu, J. , Xu, P.
  • Journal: Viruses
  • Year: 2024

"Identification of mitochondria-related biomarkers in influenza viral pneumonia and potential mechanism of Yinqiao Anti-infective Powder" 

  • Authors: Wu, Z. , Wu, Y. , Zhang, Y. , Liu, J. , Xu, P.
  • Journal: Chinese Traditional and Herbal Drugs
  • Year: 2024

"Analysis and identification of potential type II helper T cell (Th2)-Related key genes and therapeutic agents for COVID-19" 

  • Authors: Jin, Q. , Li, W. , Yu, W. , Liu, J. , Xu, P.
  • Journal: Computers in Biology and Medicine
  • Year: 2022

"Geraniin as a potential inhibitor of SARS-CoV-2 3CLpro" 

  • Authors: Yu, W.-D. , Jin, Q.-Y. , Zeng, M.-S. , Liu, J.-Y. , Xu, P.-P
  • Journal: Natural Product Research
  • Year: 2022

"Effect of paeoniflorin on acute lung injury induced by influenza A virus in mice. Evidences of its mechanism of action" 

  • Authors: Yu, W. , Zeng, M. , Xu, P. , Liu, J. , Wang, H.
  • Journal: Phytomedicine
  • Year: 2021

Haifeng Shi | Infectious Diseases | Excellence in Research 

Posted on by PencisLeave a Comment on Haifeng Shi | Infectious Diseases | Excellence in Research 

Dr. Haifeng Shi | Infectious Diseases | Excellence in Research 

Jiangsu University | China

Author Profile

Scopus

Dr. Shi Haifeng: Pioneer in Metal Toxicology and Cell Damage Detection 🔬

EARLY ACADEMIC PURSUITS 🎓

Dr. Shi Haifeng's academic journey began with a Bachelor’s degree in Biochemistry from Nanjing University in 1998. His passion for biochemistry led him to pursue a Ph.D. at the Hong Kong University of Science and Technology, where he studied under the mentorship of Professor Hong Xue, earning his doctorate in 2002. This foundation set the stage for his future groundbreaking research in the field of metal ion metabolism and toxicity.

PROFESSIONAL ENDEAVORS 🧑‍🔬

After obtaining his Ph.D., Dr. Shi continued his work at the Hong Kong University of Science and Technology as a Research Associate from 2002 to 2004, further honing his research skills. He then embarked on an international academic experience as a Visiting Scholar at the National Institutes of Health (NIH), specifically within the Liver Diseases Branch of the NIDDK, from 2004 to 2009. His time at the NIH allowed him to deepen his expertise in molecular toxicology and disease mechanisms.

CONTRIBUTIONS AND RESEARCH FOCUS ON INFECTIOUS DISEASES🧪

Dr. Shi’s research is focused on the metabolism and biological toxicity of metal ions such as iron, copper, and cadmium. His work is crucial in understanding how these metals impact biological systems, particularly in the context of heavy metal nephropathy. Additionally, his innovative work on the use of cell-free circulating cfDNA in blood as a biomarker for tissue cell damage has broad applications in medical diagnostics and environmental toxicology. His experimental models, which include yeast, silkworms, and mice, have helped to clarify the toxicological effects of metals at both molecular and systemic levels.

IMPACT AND INFLUENCE 🌍

Dr. Shi’s contributions to the scientific community are widely recognized. He has published over 70 research papers in prestigious international journals. One of his papers was recommended by Professor Alan Parrish from the University of Missouri-Columbia and listed by "Faculty Opinions" (formerly F1000Prime), a distinction reserved for papers with significant impact on their field. Another of his publications has been selected as an ESI Highly Cited Paper, placing him among the top 1% of researchers in his field.

ACADEMIC CITATIONS 📚

Dr. Shi’s work is highly cited, and his recognition as an ESI Highly Cited Researcher underscores his influence on the global scientific community. His papers continue to guide researchers in the fields of toxicology, nephropathy, and medical diagnostics.

LEGACY AND FUTURE CONTRIBUTIONS 🏅

Dr. Shi Haifeng’s legacy lies in his groundbreaking work on the biological effects of heavy metals and his innovative use of cfDNA in disease detection. As a leader in his field, his future contributions are expected to expand the frontiers of biochemistry and toxicology, with significant implications for both environmental health and clinical medicine. His continued dedication to both research and education ensures that he will remain an influential figure in his field for years to come.

NOTABLE PUBLICATIONS 📑

"Cadmium promoted LPS-induced inflammation through TLR4/IκBα/NFκ-B signaling by increasing ROS-mediated incomplete autophagy" 

  • Authors: Guo, C. , Ruan, J. , Li, Z. , Gu, J. , Shi, H.
  • Journal: Ecotoxicology and Environmental Safety
  • Year: 2024

"From ferroptosis to cuproptosis, and calcicoptosis, to find more novel metals-mediated distinct form of regulated cell death" 

  • Authors: Gu, J. , Guo, C. , Ruan, J. , Gong, X. , Shi, H.
  • Journal: Apoptosis
  • Year: 2024

"Stimuli-triggered multilayer films in response to temperature and ionic strength changes for controlled favipiravir drug release" 

  • Authors: Xu, L. , He, L. , Li, Y. , Shi, H. , Zhu, C.
  • Journal: Biomedical Materials (Bristol)
  • Year: 2024

"Energy storage enabled by cross-linked multilayer films using block copolymer-modified nanocapsules and chitosan biopolymers" 

  • Authors: Xu, L. , Li, Y. , Cai, T. , Chu, Z. , Shen, X
  • Journal: Macromolecular Research
  • Year: 2024

"Analysis of the primary factors influencing donor derived cell-free DNA testing in kidney transplantation" 

  • Authors: Cao, C. , Yuan, L. , Wang, Y. , Shi, H. , Jiang, T.
  • Journal: Frontiers in Immunology
  • Year: 2024